Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GYRE | GYRE THERAPEUTICS INC | $7.12 | $4.37 | 62.95% | 118.67x | -21.81x | 5.46x | 6.51x | 0.61x | -$150.00k | -0.03% | $106.03M | 1.19 | $654.25M | 50.95 | ||
| SLNO | SOLENO THERAPEUTICS INC | $52.25 | $40.68 | 28.45% | 130.63x | 13.17x | 13.94x | 5.99x | 0.47x | $46.73M | 1.76% | $450.12M | 8.86 | $2.68B | 92.44 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $9.74 | $18.39 | -47.03% | 6.96x | 19.65x | 5.06x | 3.70x | 0.31x | -$1.99M | -0.37% | $154.66M | 2.80 | $572.65M | 5.77 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $330.34 | $78.50 | 320.80% | 138.22x | 48.40x | 11.65x | 55.51x | 1.75x | $465.38M | 1.08% | $789.18M | 6.02 | $45.12B | 71.46 | ||
| ADMA | ADMA BIOLOGICS INC | $9.28 | $11.47 | -19.09% | 14.97x | 9.53x | 4.33x | 4.63x | 0.40x | $27.82M | 1.26% | $477.32M | 2.00 | $2.20B | 11.10 | ||
| CORT | CORCEPT THERAPEUTICS INC | $40.85 | $20.37 | 100.57% | 43.00x | 75.29x | 5.57x | 6.71x | 0.93x | $141.79M | 3.34% | $647.81M | 6.24 | $4.23B | 93.59 | ||
| KRYS | KRYSTAL BIOTECH INC | $261.80 | $107.12 | 144.40% | 36.98x | 33.62x | 19.47x | 6.28x | 1.32x | $189.35M | 2.50% | $1.22B | 42.14 | $7.17B | 36.56 | ||
| HALO | HALOZYME THERAPEUTICS INC | $63.08 | $69.23 | -8.89% | 23.89x | 7.71x | 5.41x | 152.51x | 0.40x | $644.59M | 8.53% | $48.81M | 0.41 | $9.45B | 16.49 | ||
| RPRX | ROYALTY PHARMA PLC | $47.32 | $41.13 | 15.05% | 26.44x | 9.16x | 8.55x | 2.81x | 0.52x | $2.22B | 10.91% | $9.71B | 22.60 | $35.63B | 33.03 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $4.47 | $3.30 | 35.35% | 20.32x | 16.08x | 2.73x | 4.68x | 0.73x | $13.21M | 3.74% | $76.53M | 0.97 | $295.99M | 15.07 | ||
| VCEL | VERICEL CORP | $34.08 | $8.34 | 308.59% | 103.27x | 77.24x | 6.21x | 4.88x | 1.80x | $24.75M | 1.44% | $354.64M | 7.05 | $1.73B | 49.46 | ||
| TECH | BIO-TECHNE CORP | $53.80 | $15.34 | 250.69% | 103.46x | 26.60x | 6.90x | 4.19x | 1.49x | $223.02M | 2.66% | $2.01B | 12.90 | $8.60B | 37.96 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $56.21 | $46.47 | 20.96% | 30.88x | 12.86x | 3.35x | 1.78x | 0.53x | $724.96M | 6.72% | $6.09B | 31.74 | $10.10B | 17.62 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $40.63 | $4.99 | 713.83% | 225.72x | -34.44x | 5.11x | 14.03x | 3.51x | $45.01M | 0.88% | $370.15M | 2.93 | $5.20B | 74.30 | ||
| MNKD | MANNKIND CORP | $2.56 | $1.06 | 142.19% | 128.00x | 294.25x | 2.24x | -15.46x | 0.94x | $13.69M | 1.76% | -$51.02M | -0.17 | $1.32B | 24.92 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $27.71 | $35.60 | -22.17% | 10.04x | 7.55x | 1.83x | 1.84x | 0.47x | $347.89M | 21.84% | $870.22M | 15.14 | $1.01B | 3.98 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $203.61 | $108.06 | 88.43% | 31.62x | 21.24x | 14.69x | 3.99x | 0.97x | $48.09M | 1.22% | $1.02B | 52.60 | $4.34B | 21.75 | ||
| EXEL | EXELIXIS INC | $43.98 | $34.79 | 26.41% | 15.27x | 13.76x | 5.15x | 5.28x | 0.80x | $875.84M | 7.33% | $2.16B | 7.96 | $11.11B | 11.17 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $434.30 | $184.17 | 135.82% | 28.09x | 22.30x | 9.25x | 5.91x | 1.50x | $3.19B | 2.88% | $18.67B | 73.00 | $107.09B | 22.01 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $24.98 | $14.68 | 70.15% | 14.27x | 13.03x | 5.19x | 3.20x | 1.67x | $208.61M | 6.83% | $954.27M | 7.80 | $2.34B | 7.29 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $763.04 | $434.44 | 75.64% | 17.72x | 16.28x | 5.56x | 2.58x | 1.32x | $4.08B | 5.11% | $31.26B | 298.82 | $80.26B | 13.79 | ||
| UTHR | UNITED THERAPEUTICS CORP | $559.65 | $264.08 | 111.92% | 18.57x | 19.15x | 7.79x | 3.46x | 1.93x | $1.04B | 4.20% | $7.10B | 160.19 | $22.97B | 12.63 | ||
| INCY | INCYTE CORP | $94.86 | $67.00 | 41.59% | 14.39x | 12.26x | 3.60x | 3.65x | 1.05x | $1.35B | 7.32% | $5.17B | 26.47 | $15.81B | 8.98 | ||
| VCYT | VERACYTE INC | $32.32 | $10.13 | 219.18% | 38.48x | 30.49x | 4.91x | 1.96x | 2.01x | $126.63M | 4.98% | $1.31B | 16.67 | $2.24B | 24.23 | ||
| MDXG | MIMEDX GROUP INC | $3.88 | $1.85 | 109.54% | 11.76x | 34.58x | 1.37x | 2.25x | 22.75x | $72.97M | 12.73% | $256.55M | 1.74 | $428.28M | 5.39 | ||
| XOMA | XOMA ROYALTY CORP | $33.75 | $9.87 | 241.97% | 22.06x | 68.93x | 7.82x | 4.79x | 7.50x | -$1.83M | -0.45% | $83.94M | 6.95 | $445.02M | 12.83 | ||
| PBYI | PUMA BIOTECHNOLOGY INC | $6.89 | $3.85 | 78.80% | 11.11x | 16.89x | 1.51x | 2.69x | 4.92x | $41.73M | 12.10% | $130.34M | 2.61 | $347.36M | 6.51 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.